Gover Justin D. 4

What Happened Justin D. Gover, a director of Design Therapeutics, was granted a derivative award covering 30,000 shares on June 9, 2026. The Form 4 reports an acquisition price of $0.00 for the award (reported value $0). This transaction is a grant/acquisition (not a sale) — typically a form of compensation or incentive rather than an open-market purchase.

Key Details

• Transaction date: 2026-06-09; Form 4 filed: 2026-06-11 (Period of Report: 2026-06-09). Filing appears timely.
• Reported transaction: Grant/award of 30,000 shares (derivative) at $0.00 per share; total reported consideration $0.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: The shares subject to the option vest in equal monthly installments over 12 months following June 9, 2026, and will be fully vested by the company’s next annual meeting of stockholders.
• No indication this was a cashless exercise or an immediate sale; this is a vesting-based award.

Context This filing documents a director compensation grant (a derivative award/option) rather than a market purchase or sale. Vesting over 12 months means the economic interest accrues over time and may affect when shares are actually owned or sold. The filing does not disclose motivations or any immediate disposition of shares.